Recent advances in natural language processing (NLP) can be largely attributed to the advent of pre-trained language models such as BERT and RoBERTa. While these models demonstrate remarkable performance on general datasets, they can struggle in specialized domains such as medicine, where unique domain-specific terminologies, domain-specific abbreviations, and varying document structures are common. This paper explores strategies for adapting these models to domain-specific requirements, primarily through continuous pre-training on domain-specific data. We pre-trained several German medical language models on 2.4B tokens derived from translated public English medical data and 3B tokens of German clinical data. The resulting models were evaluated on various German downstream tasks, including named entity recognition (NER), multi-label classification, and extractive question answering. Our results suggest that models augmented by clinical and translation-based pre-training typically outperform general domain models in medical contexts. We conclude that continuous pre-training has demonstrated the ability to match or even exceed the performance of clinical models trained from scratch. Furthermore, pre-training on clinical data or leveraging translated texts have proven to be reliable methods for domain adaptation in medical NLP tasks.
We consider a missing data problem in the context of automatic segmentation methods for Magnetic Resonance Imaging (MRI) brain scans. Usually, automated MRI scan segmentation is based on multiple scans (e.g., T1-weighted, T2-weighted, T1CE, FLAIR). However, quite often a scan is blurry, missing or otherwise unusable. We investigate the question whether a missing scan can be synthesized. We exemplify that this is in principle possible by synthesizing a T2-weighted scan from a given T1-weighted scan. Our first aim is to compute a picture that resembles the missing scan closely, measured by average mean squared error (MSE). We develop/use several methods for this, including a random baseline approach, a clustering-based method and pixel-to-pixel translation method by (Pix2Pix) which is based on conditional GANs. The lowest MSE is achieved by our clustering-based method. Our second aim is to compare the methods with respect to the affect that using the synthesized scan has on the segmentation process. For this, we use a DeepMedic model trained with the four input scan modalities named above. We replace the T2-weighted scan by the synthesized picture and evaluate the segmentations with respect to the tumor identification, using Dice scores as numerical evaluation. The evaluation shows that the segmentation works well with synthesized scans (in particular, with Pix2Pix methods) in many cases.
Nuclei detection and segmentation in hematoxylin and eosin-stained (H&E) tissue images are important clinical tasks and crucial for a wide range of applications. However, it is a challenging task due to nuclei variances in staining and size, overlapping boundaries, and nuclei clustering. While convolutional neural networks have been extensively used for this task, we explore the potential of Transformer-based networks in this domain. Therefore, we introduce a new method for automated instance segmentation of cell nuclei in digitized tissue samples using a deep learning architecture based on Vision Transformer called CellViT. CellViT is trained and evaluated on the PanNuke dataset, which is one of the most challenging nuclei instance segmentation datasets, consisting of nearly 200,000 annotated Nuclei into 5 clinically important classes in 19 tissue types. We demonstrate the superiority of large-scale in-domain and out-of-domain pre-trained Vision Transformers by leveraging the recently published Segment Anything Model and a ViT-encoder pre-trained on 104 million histological image patches - achieving state-of-the-art nuclei detection and instance segmentation performance on the PanNuke dataset with a mean panoptic quality of 0.51 and an F1-detection score of 0.83. The code is publicly available at https://github.com/TIO-IKIM/CellViT